WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H591292
CAS#: 307-43-7
Description: Perflubrodec is a component of an intravascular temporary oxygen carrier that is intended to enhance oxygen transport.
Hodoodo Cat#: H591292
Name: Perflubrodec
CAS#: 307-43-7
Chemical Formula: C10BrF21
Exact Mass: 597.88
Molecular Weight: 598.980
Elemental Analysis: C, 20.05; Br, 13.34; F, 66.61
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Perflubrodec; AF0144; AF-0144; AF 0144
IUPAC/Chemical Name: 1-Bromohenicosafluorodecane
InChi Key: JCAULFRGWRHHIG-UHFFFAOYSA-N
InChi Code: InChI=1S/C10BrF21/c11-9(28,29)7(24,25)5(20,21)3(16,17)1(12,13)2(14,15)4(18,19)6(22,23)8(26,27)10(30,31)32
SMILES Code: BrC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 598.98 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Anastácio A, Rodriguez-Wallberg KA, Chardonnet S, Pionneau C, Fédérici C, Almeida Santos T, Poirot C. Protein profile of mouse ovarian follicles grown in vitro. Mol Hum Reprod. 2017 Dec 1;23(12):827-841. doi: 10.1093/molehr/gax056. PubMed PMID: 29069483; PubMed Central PMCID: PMC5909860.
2: Dagres N, Varounis C, Iliodromitis EK, Lekakis JP, Rallidis LS, Anastasiou-Nana M. Dronedarone and the incidence of stroke in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis of randomized trials. Am J Cardiovasc Drugs. 2011 Dec 1;11(6):395-400. doi: 10.2165/11594200-000000000-00000. Review. PubMed PMID: 22149318.
3: Liu B, Yang JF, Luo Y, Fang F, Liu DG. [Investigate the relation between atrial fibrillation and coronary heart disease in the elderly: an analysis of pathological data of 509 cases]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Feb;35(2):110-3. Chinese. PubMed PMID: 17445400.
